3 days until Unite to Fight! If you don't live in Boulder, you can purchase livestream access here: tinyurl.com/2p8xfxxt Just like regular tickets, livestream sales will go to charity! Sophie’s Neighborhood

Our CEO, Joey Azofeifa, will be talking at the BIO International Convention about how we're developing therapies for diseases driven by transcription factors! Please check out his talk on Wednesday June 7th at 4:15p ET in Room 104B! #StandUpForScience #BIO2023

Awesome job to Dave Simpson for repping Arpeggio yesterday at the CU Boulder 🦬 Core Facilities Open House and Local Industry Fair!

The Arpeggio team loves a good happy hour! Lots of good science to celebrate this month #teambuilding #drugdiscovery

We’re incredibly excited to publish the inaugural edition of the Decoding Bio Snapshot. Several months in the making, it profiles 40 companies operating at the intersection of computation and biology, ranging from pre-seed to publicly traded. snapshot.decodingbio.com

Friday ice cream from Blackbelly in support of our very favorite Arpeggio Junior Scientist, Sophie! ❤️ Join us by enjoying sweet treats this Sunday from their list of partners in the link below – Sophie’s Neighborhood

How inspiring that we've made GS's Impact100, an annual list of the world's 100 most promising impact #startups - this list exists to give you energy, hope, and positive inspiration! #100waystofixthefuture #NASDAQ

Good luck today Joey Azofeifa!

How cool that two of our very own, Laura Norris and Joey Azofeifa have received the #40under40 award from BizWest! This certainly reflects their dedication and hard work. The Boulder biotech community and Arpeggio team is lucky to have you both! #risingstars

Laura Norris and @joeyazofeifa had a great night celebrating @BizWestMedia 40 Under Forty Class of 2023! Congratulations to all the honorees shaping the future of the Colorado Life Science community! #BW40UnderForty

We're thrilled to be selected by Colorado BioScience Association as a Rising Star of the Year Award finalist! It's a great tribute to the Arpeggio team. Together, we are changing the way we discover drugs, and we will continue to move toward our goal of developing therapies for rare diseases.

Strong Arpeggio representation at SLAS with Tim Read and Casey Pham both presenting today in collaboration with Beckman Coulter Life Sciences and Biosero 👏 Be sure to connect with our team if you're there!

The team’s at AACR this week and looking forward to sharing our GPX4 inhibitor combining with a checkpoint inhibitor (anti-PDL1) to dramatically slow the progression of sarcoma in mice! Please visit our poster on Monday, April 8th from 1:30-5:00, Section 52, Board 10.

We’re also very excited to present our NRF2 degrader at AACR! This amazing small molecule leads to regression of aggressive lung adenocarcinoma tumors in vivo and was discovered using our AI + transcriptomics platform. Stop by on April 8th from 1:30-5:00, Section 52, Board 15.

We loved working with the very talented team at Wunderdogs on Arpeggio's new website and look! Check out their case study below if you're curious about the inspiration behind our design – they captured the story of our company beautifully. wunderdogs.co/cases/arpeggio…

We're so proud to announce Kevin Eastwood as Arpeggio's Chief Business Officer and to have worked with the incredible team at Slone Partners. Welcome, Kevin! We are truly thrilled to join forces with you. slonepartners.com/kevin-eastwood…

Attend #medSCAI24—our 3rd annual symposium on medicines, single cell tech & #AI! Join leaders for two sessions on AI & #MachineLearning-powered #DrugDiscovery. Featuring Arpeggio Biosciences, MIT Dept of BE, UW Genome Sciences, Novartis & more. Register ➡️ bit.ly/3yOdJEL